• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Delivering Better Gut Health Supplements

    Delivering Dietary Supplements that Exceed Consumer Expectations

    Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses

    Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations

    Optimizing Gut Health: Unlocking the Gates to Well-Being
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval

    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits

    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress

    Arla Foods Enters New Partnership to Reduce Malnutrition With Dried Papaya Snack

    Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval

    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits

    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress

    Arla Foods Enters New Partnership to Reduce Malnutrition With Dried Papaya Snack

    Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval

    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits

    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress

    Arla Foods Enters New Partnership to Reduce Malnutrition With Dried Papaya Snack

    Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval

    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits

    Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure

    Study Finds People With Obesity are More Responsive To Food Marketing – Until Their Weight Drops

    Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Xsto Solutions

    Indena USA, Inc.

    Sabinsa Corporation

    Vesta Nutra

    Gencor
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    AIDP

    Bioenergy Life Science, Inc. (BLS)

    Sabinsa Corporation

    Nutrition21, LLC

    KLK OLEO - Davos Life Science
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Content Microsite

    Will an EPA Drug Candidate Be Used to Treat COVID-19?

    EPAspire, which contains EPA free fatty acids and sweet wormwood extract, is undergoing clinical trials as a possible treatment for COVID-19

    Will an EPA Drug Candidate Be Used to Treat COVID-19?
    Clinical trials for EPAspire have already begun, and will soon be taking place in several European countries.
    04.16.20
    KD Pharma and its partner, SLA Pharma, have announced that its new drug candidate, EPAspire, will be used in clinical trials as a possible candidate to treat patients with COVID-19 symptoms. The MHRA in the U.K. has approved the trial nad late-stage discussions are going on with authorities in other European countries, and an application has been submitted to the U.S. Food and Drug Administration (FDA).
     
    EPAspire’s main active ingredients are EPA free fatty acids and a sweet wormwood extract.
     
    “We hope EPAspire will be able to reduce the risk of coronavirus complications progressing to serious outcomes like ARDS (Acute Respiratory Distress Syndrome), the need for artificial ventilation, and intensive care,” Oscar Goet, KD Pharma CEO. “This unique preparation has potential, to not only modify the COVID-19 disease process, reducing harmful, excess inflammatory responses, but to do so without suppressing the immune response to the virus which is cvital to seroconversion giving the patient ongoing protection against continued viral challenge.”
     
    SLA reports that it is “leading the clinical development to expedite the trials in various countries working closely with the respective regulatory authorities,” SLA CEO Justin Slagel said.
     
    Eligible patients with a positive COCVID-19 test result will be able to participate in the trial, and, after enrollment, will be givent the product within a day of hospitalization and continue treatment for one month with a two-week follow up. They will be monitored for progression to more serious outcomes and markers of inflammation, with the aim that EPAspire could help reduce the risk of mortality in severely ill patients.
     
    EPAspire is a unique, novel formulation of highly purified EPA free fatty acid in gastro-resistant capsules which deliver it to the gut at optimal pH to allow for maximal absorption. EPAspire is currently in a clinical trial in Europe for the treatment of familial adenomatous polyposis (FAP). Proprietary data from the FAP trials suggests that it suppresses expression of inflammatory cytokines believed to contribute to the progression of COVID-19 symptoms. Since the drug is currently in a Phase 3 trial for FAP in multiple countries, the companies have been able to initiate the COVID-19 trials very rapidly. The safety profile of EPAspire is well established from previous clinical studies.
     
    The primary investigators in Italy who designed the protocol believe EPA-FFA may change the course of COVID-19 by modulating immune response and protecting patients from its most severe complications.
     
    “EPA is a free fatty acid that is very promptly absorbed and incorporated into the body’s phospholipid membranes, and then starts to act very quickly,” the investigators wrote. “Once incorporated into cell membranes, EPA-FFA significantly affefcts the production of pro-inflammatory mediators such as IL-6 and leukotriene B4 that play a crucial role in starting and maintaining the inflammatory process in the lungs. Moreover, EPA-FFA metabolism generates pro-resolving mediators and bioactive metabolites that enhance innate microbial killing and organ protection.”
     
     
    Related Searches
    • Inflammation
    • fda
    • covid-19
    • Extract
    Related Knowledge Center
    • Immune Function
    • Medical Nutrition
    • Contract Manufacturing

    Related Content Microsite

    • Breaking News | Regulations | Regulatory News | World Markets
      21 Additional Companies Accused of COVID-19 Scam Marketing

      21 Additional Companies Accused of COVID-19 Scam Marketing

      Purveyors of dietary supplements, IV 'therapies,' and ozone 'therapies' were accused by the FTC of purporting that their products could fight COVID-19.
      04.23.20

    • Breaking News | Regulations | Regulatory News | World Markets
      Coronavirus Supplement Scams Persist Across U.S. as FTC Announces Latest Offenders

      Coronavirus Supplement Scams Persist Across U.S. as FTC Announces Latest Offenders

      The agency states that it has responded to more than 25 supplement companies promising a cure, treatment, or prevention of COVID-19.
      04.17.20

    • Breaking News | Contract Manufacturing | People News | Quality & Safety | Regulations | Regulatory News
      FDA Deputy Commissioner Frank Yiannas Discusses State of Food Industry

      FDA Deputy Commissioner Frank Yiannas Discusses State of Food Industry

      In a Q&A session, the FDA official breaks down his takeaways amid the COVID-19 pandemic.
      04.17.20


    • Healthcare Trends | Medical Nutrition | World Markets
      Nestlé Responds to Global Pandemic, Partners with International Federation of the Red Cross

      Nestlé Responds to Global Pandemic, Partners with International Federation of the Red Cross

      Company said it’s worked closely with physicians to develop new tailored COVID-19 medical nutrition and supplement treatment protocols.
      03.26.20

    • Breaking News | Immune Function | Industry & Market News | Regulations
      GOED Advises Omega-3 Companies Not to Make Viral Immunity Claims

      GOED Advises Omega-3 Companies Not to Make Viral Immunity Claims

      A search through every human clinical trial on omega-3s yielded zero conclusive evidence that omega-3s have a role in viral immunity, GOED said.
      03.24.20

    • Breaking News | Industry & Market News | Supplier News | World Markets
      PepsiCo Ramps Up Employee Benefits, Announces COVID-19 Donations

      PepsiCo Ramps Up Employee Benefits, Announces COVID-19 Donations

      The company plans to fully compensate all U.S. frontline employees affected by the coronavirus.
      03.23.20


    • Breaking News | Industry & Market News | Regulations | Regulatory News | World Markets
      CRN, AHPA Address Ongoing COVID-19 FAQs

      CRN, AHPA Address Ongoing COVID-19 FAQs

      With much on the line for all types of industries, natural products trade groups aim to keep companies up to date.
      03.23.20

    • Breaking News | Industry & Market News | Packaging | Quality & Safety | Regulations | Regulatory News | World Markets
      NPA Proposes COVID-19 Safety Measures in Light of FDA

      NPA Proposes COVID-19 Safety Measures in Light of FDA's Inspection Rollbacks

      The Natural Products Association calls for Import Alert and expansion of Supplement Safety and Compliance Initiative.
      03.20.20

    • Consumer Trends | Healthcare Trends | World Markets
      Stakeholders Act to Ensure Strong Food Supply Lines

      Stakeholders Act to Ensure Strong Food Supply Lines

      The grocery supply chain will be tested, but remains resilient, according to experts.
      Sean Moloughney, Editor, Nutraceuticals World 03.19.20


    • Breaking News | Quality & Safety | Regulations | Regulatory News | World Markets
      FDA Halts Domestic Inspections Indefinitely

      FDA Halts Domestic Inspections Indefinitely

      After postponing overseas supply chain audits, FDA announced it will no longer be conducting on-site inspections domestically for the time being.
      03.19.20

    • Breaking News | Industry & Market News | Quality & Safety | Regulations | Regulatory News | World Markets
      COVID-19 Supply Chain Impact: The Story So Far

      COVID-19 Supply Chain Impact: The Story So Far

      TraceGains CEO Gary Nowacki shared insights on how the pandemic may affect global supply chains in the nutrition/supplement industry.
      Mike Montemarano, Associate Editor, Nutraceuticals World 03.19.20

    • Breaking News | Industry & Market News | Quality & Safety | Regulations | Supplier News | World Markets
      Sabinsa Announces COVID-19 Response

      Sabinsa Announces COVID-19 Response

      The health nutrition company ramped up its health and safety policies, and anticipates no supply chain disruptions will be caused.
      03.18.20


    Trending
    • CGA-7 Green Coffee Extract By Vidya Herbs Achieves Self-Affirmed GRAS Status
    • Several Studies Evaluate Role Of Vitamin D In COVID-19 Outcomes
    • Review Covers Role Of Vitamin K2 In The ‘Calcium Paradox’
    • BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA 'Letter Of No Objection' On GRAS Status
    • Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass In Older Adults
    Breaking News
    • AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    • Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    • FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    • Arla Foods Enters New Partnership to Reduce Malnutrition With Dried Papaya Snack
    • Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Optimizing Gut Health: Unlocking the Gates to Well-Being
    • Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations
    • Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses
    • Delivering Dietary Supplements that Exceed Consumer Expectations
    • Delivering Better Gut Health Supplements
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    Evonik Highlights Solutions for Malodor Reduction
    P&G Emphasizes Small Actions at Home To Be More Sustainable
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login